Trial
NCT03887702
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
SWOG Cancer Research Network
Collaborators
National Cancer Institute (NCI)
Condition
Hepatitis B Infection
Intervention
Best Practice
Why stopped
inability to accrue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-20